ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Califano Insists On Search Committee To Look for NCI Chief; Brown Still In Running

February 25, 1977

Congress Signals Willingness to Break With Administration on NIH Funding.

March 24, 2006

Satcher Nominated For Surgeon General, Asst. Sec. for Health.

September 19, 1997

Avon Awards $30M To 13 Organizations

September 27, 2002